These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 22929594
21. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants. Chen B, Xu H, Corbin DR, Ildstad ST. Transplantation; 2012 Oct 15; 94(7):671-8. PubMed ID: 22948444 [Abstract] [Full Text] [Related]
25. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R. Transplantation; 2011 Dec 27; 92(12):1301-8. PubMed ID: 22082819 [Abstract] [Full Text] [Related]
26. Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation. Chen Y, Fukuda T, Thakar MS, Kornblit BT, Storer BE, Santos EB, Storb R, Sandmaier BM. Cytotherapy; 2011 Nov 27; 13(10):1269-80. PubMed ID: 21846291 [Abstract] [Full Text] [Related]
27. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Kuhr CS, Allen MD, Junghanss C, Zaucha JM, Marsh CL, Yunusov M, Zellme E, Little MT, Torok-Storb B, Storb R. Transplantation; 2002 May 15; 73(9):1487-92. PubMed ID: 12023629 [Abstract] [Full Text] [Related]
28. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation. Sorror ML, Leisenring W, Mielcarek M, Baron F, Diaconescu R, Hogan WJ, Graves SS, Storb R. Transplantation; 2008 Apr 15; 85(7):1023-9. PubMed ID: 18408584 [Abstract] [Full Text] [Related]
29. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M. Biol Blood Marrow Transplant; 2001 Apr 15; 7(12):646-55. PubMed ID: 11787527 [Abstract] [Full Text] [Related]
30. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Zaucha JM, Zellmer E, Georges G, Little MT, Storb R, Storer B, Torok-Storb B. Biol Blood Marrow Transplant; 2001 Apr 15; 7(11):613-9. PubMed ID: 11760149 [Abstract] [Full Text] [Related]
32. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM, Ganguly S, Vulic A, Panoskaltsis-Mortari A, McDyer JF, Luznik L. Transplantation; 2016 Dec 15; 100(12):e140-e146. PubMed ID: 27861294 [Abstract] [Full Text] [Related]
33. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients. Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI. Transplant Proc; 2005 Mar 15; 37(2):737-42. PubMed ID: 15848518 [Abstract] [Full Text] [Related]
34. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, Ciancio G, Burke G, Roth D, Temple D, Fuller L, Esquenazi V, Eskind L, Kenyon NS, Ricordi C, Tzakis A, Miller J. Transplantation; 1998 Apr 15; 65(7):956-65. PubMed ID: 9565101 [Abstract] [Full Text] [Related]
35. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance. Johnstone BH, Messner F, Brandacher G, Woods EJ. Front Immunol; 2021 Apr 15; 12():622604. PubMed ID: 33732244 [Abstract] [Full Text] [Related]
36. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Tomita Y, Sachs DH, Khan A, Sykes M. Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363 [Abstract] [Full Text] [Related]
37. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD, Pham S, Li S, Aitouche A. Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367 [Abstract] [Full Text] [Related]
38. Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice. Willems L, Fevery S, Sprangers B, Rutgeerts O, Lenaerts C, Ibrahimi A, Gijsbers R, Van Gool S, Waer M, Billiau AD. Cancer Immunol Immunother; 2013 Nov 27; 62(11):1733-44. PubMed ID: 24081484 [Abstract] [Full Text] [Related]
39. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment. Neipp M, Gammie JS, Exner BG, Li S, Chambers WH, Pham SM, Ildstad ST. Transplantation; 1999 Aug 15; 68(3):369-78. PubMed ID: 10459540 [Abstract] [Full Text] [Related]
40. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Lee WS, Suzuki Y, Graves SS, Iwata M, Venkataraman GM, Mielcarek M, Peterson LJ, Ikehara S, Torok-Storb B, Storb R. Biol Blood Marrow Transplant; 2011 Apr 15; 17(4):465-75. PubMed ID: 20457265 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]